Will Thomas: Why Dose Every Missed Thromboprophylaxis Matter
Will Thomas, Consultant haematologist at Cambridge University Hospitals NHS Foundation Trust, shared on LinkedIn about a recent article by Scott G. Louis et al, published in JAMA Surgery, adding:
“Experts are often asked to give an opinion on causation when there had been missed prophylactic low-molecular weight heparin doses and hospital acquired thrombosis.
One of the few things we can do is to avoid missed doses. This was identified by a previous GIRFT survey in 2021.
Every case is unique and requires meticulous attention to the circumstances and particular details of the case.
This paper gives valuable data in this area.
Which is helpful for experts albeit data remains limited.”
Title: Correlation of Missed Doses of Enoxaparin With Increased Incidence of Deep Vein Thrombosis in Trauma and General Surgery Patients
Authors: Scott G. Louis, Misa Sato, Travis Geraci, Ross Anderson, S. David Cho, Philbert Y. Van, Jeffrey S. Barton, Gordon M. Riha, Samantha Underwood, Jerome Differding, Jennifer M. Watters, Martin A. Schreiber
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight
-
Aug 14, 2026, 18:20Venkata Sagi: Systemic Anticoagulation or Left Atrial Appendage Closure?
-
Aug 14, 2026, 18:02Marios Psychogios: Every Minute Matters in Acute Stroke Care
-
Aug 14, 2026, 17:57Molly Lippold-Meinholz: The Magic of Camp for Kids With Bleeding Disorders
-
Aug 14, 2026, 17:42Nandini Pethe: Representing MicroHealth at BDC
-
Aug 14, 2026, 17:30Richard Habis: Hemophilia Does Not Only Affect the Child
-
Aug 14, 2026, 17:00Zahra Safarzadeh: The Critical Role of the Laboratory in Hemophilia Care
-
Aug 14, 2026, 16:39Yuriy Prokopenko: Advancing Hemostasis Through Scientific Collaboration